Antares Pharma, Inc. (ATRS)

[jab91252]

whogo:

Regarding your statement: "I've thought about that possibility a few times, but they've sort of mislead investors if it turns out to be true. QSM is supposed to be another internally developed program whereas Copaxone would be a partnered program. I like that idea a whole lot more then Methylcobalamin."

Why couldn't QSM be completely internal at this point? Who's to say it would not develop into something more down the road with TEVA letting them (knowing or unknowingly) take the lead? In the meantime, the trials you mention are or would be or will be conducted. Eventually, a generic Copaxone will be approved I believe and TEVA may see the writing on the wall. I recall maybe a couple years ago, then US TEVA guy, Bill Marth, made the statement that TEVA knows Copaxone is on its last legs or something to that effect.

Just letting the brain dump continue....